The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 24, 2019

Filed:

Jun. 26, 2017
Applicant:

Ziolase, Llc, Winter Springs, FL (US);

Inventors:

Svetlana A. Ivanova, Winter Springs, FL (US);

Dennis W. Davis, Palm Bay, FL (US);

Brad W. Arenz, Orlando, FL (US);

Thomas K. Connellan, Charlottesville, FL (US);

Assignee:

ZIOLASE, LLC, Winter Springs, FL (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 9/24 (2006.01); A61K 38/47 (2006.01); A01N 63/00 (2006.01); A61K 9/00 (2006.01); A61K 9/70 (2006.01); A61Q 11/00 (2006.01); A61K 8/66 (2006.01); A01N 63/02 (2006.01); A61P 31/04 (2006.01); A61K 38/14 (2006.01); A61K 31/496 (2006.01); A61K 31/546 (2006.01); A61K 31/7036 (2006.01);
U.S. Cl.
CPC ...
A61K 38/47 (2013.01); A01N 63/00 (2013.01); A01N 63/02 (2013.01); A61K 8/66 (2013.01); A61K 9/006 (2013.01); A61K 9/7007 (2013.01); A61K 31/496 (2013.01); A61K 31/546 (2013.01); A61K 31/7036 (2013.01); A61K 38/14 (2013.01); A61P 31/04 (2018.01); A61Q 11/00 (2013.01); C12N 9/2405 (2013.01); C12Y 302/01028 (2013.01); Y10T 29/49826 (2015.01);
Abstract

Compositions and methods to treat biofilms are disclosed based on the discovery of the role of the disaccharide trehalose in microbial biofilm development. In various embodiments to treat body-borne biofilms systemically and locally, the method includes administering trehalase, the enzyme which degrades trehalose, in combination with other saccharidases for an exposition time sufficient to adequately degrade the biofilm gel matrix at the site of the biofilm. The method also includes administering a combination of other enzymes such as proteolytic, fibrinolytic, and lipolytic enzymes to break down proteins and lipids present in the biofilm, and administering antimicrobials for the specific type(s) of infectious pathogen(s) underlying the biofilm. Additionally, methods are disclosed to address degradation of biofilms on medical device surfaces and biofilms present in industrial settings.


Find Patent Forward Citations

Loading…